review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.2174/1566524033479726 |
P698 | PubMed publication ID | 12776992 |
P2093 | author name string | Shizuo Akira | |
Tsuneyasu Kaisho | |||
P433 | issue | 4 | |
P921 | main subject | toll-like receptor | Q408004 |
dendritic cell | Q506253 | ||
cell function | Q95674809 | ||
P304 | page(s) | 373-385 | |
P577 | publication date | 2003-06-01 | |
P1433 | published in | Current Molecular Medicine | Q5195065 |
P1476 | title | Regulation of dendritic cell function through Toll-like receptors | |
P478 | volume | 3 |
Q37209327 | A recent perspective on alcohol, immunity, and host defense. |
Q38937569 | Androgen regulation of host defenses and response to inflammatory stimuli in the prostate gland |
Q35648247 | Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens |
Q44854167 | Association of Toll-like receptor 3 polymorphisms with chronic hepatitis B and hepatitis B-related acute-on-chronic liver failure |
Q41294055 | Bisphenol A Does Not Mimic Estrogen in the Promotion of the In Vitro Response of Murine Dendritic Cells to Toll-Like Receptor Ligands. |
Q36609624 | CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells |
Q38803353 | Cell-Permeable Peptide Blocks TLR4 Signaling and Improves Islet Allograft Survival |
Q35156132 | Characterization of Toll-like receptor-4 (TLR-4) in the spleen and thymus of Swiss albino mice and its modulation in experimental endotoxemia |
Q37039741 | Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated phosphoinositide 3-kinase signaling |
Q42263287 | Chronic stress promotes lymphocyte reduction through TLR2 mediated PI3K signaling in a β-arrestin 2 dependent manner |
Q36028182 | Close encounters of different kinds: dendritic cells and NK cells take centre stage |
Q37383587 | Combinations of TLR ligands: a promising approach in cancer immunotherapy |
Q42953540 | Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure |
Q82276742 | Cytokine content in lymphoid and white adipose tissues after repeated CpG oligodeoxynucleotide administration in trained rats |
Q36119226 | Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis |
Q37960189 | Developing dendritic cell-based therapies to condition immune responses to novel oncogenic proteins and stem cells |
Q38613932 | Dual Role of p53 in Innate Antiviral Immunity |
Q37599675 | Enhancement of anti-tumor immunity by photodynamic therapy |
Q92208179 | Epistatic effect of TLR3 and cGAS-STING-IKKε-TBK1-IFN signaling variants on colorectal cancer risk |
Q81507577 | Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population |
Q92593495 | Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice |
Q36352592 | HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro |
Q38095583 | Heat-shock proteins as dendritic cell-targeting vaccines--getting warmer. |
Q36943779 | High glucose induces toll-like receptor expression in human monocytes: mechanism of activation |
Q35637206 | High glucose may decrease the innate immune through TLRs in cornea epithelium |
Q36907192 | Homing of Antigen-Presenting Cells in Head Kidney and Spleen - Salmon Head Kidney Hosts Diverse APC Types. |
Q47703446 | Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91. |
Q36539539 | Identification and characterization of Chlamydia pneumoniae-specific proteins that activate tumor necrosis factor alpha production in RAW 264.7 murine macrophages |
Q35681340 | Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity |
Q35806782 | Immunity, cancer and aging: lessons from mouse models. |
Q58003718 | In vitro-Generated Viral Double-Stranded RNA in Contrast to Polyinosinic : Polycytidylic Acid Induces Interferon-alpha in Human Plasmacytoid Dendritic Cells |
Q58553701 | In vivo cancer vaccination: Which dendritic cells to target and how? |
Q42724675 | Innate and Adaptive Immune Responses in Wound Epithelialization |
Q43626158 | Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. |
Q35828776 | Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors |
Q40446857 | Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction |
Q30479030 | Invariant NKT cells sustain specific B cell responses and memory |
Q46102734 | MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). |
Q41968893 | Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration. |
Q40456904 | Molecular characterization and analysis of TLR-1 in rabbit tissues. |
Q41877481 | MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands |
Q33714813 | MyD88-dependent induction of allergic Th2 responses to intranasal antigen. |
Q34344946 | Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9 |
Q34763764 | Myeloid decidual dendritic cells and immunoregulation of pregnancy: defective responsiveness to Coxiella burnetii and Brucella abortus |
Q97559063 | NCoR1 fine-tunes type-I IFN response in cDC1 dendritic cells by directly regulating Myd88-IRF7 axis under TLR9 |
Q37729135 | Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy |
Q37989884 | Prophylactic and therapeutic implications of toll-like receptor ligands |
Q36001067 | Reading the viral signature by Toll-like receptors and other pattern recognition receptors |
Q36933812 | Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist. |
Q36910018 | Signal relay by CC chemokine receptor 2 (CCR2) and formylpeptide receptor 2 (Fpr2) in the recruitment of monocyte-derived dendritic cells in allergic airway inflammation |
Q40382473 | Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells |
Q36313592 | Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome |
Q38766473 | TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement. |
Q37335593 | TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells |
Q37377551 | TLR9 is localized in the endoplasmic reticulum prior to stimulation |
Q38331978 | TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines |
Q42316872 | The Immunomodulatory Effect of Bone-Marrow Mesenchymal Stem Cells on Expression of TLR3 and TLR9 in Mice Dendritic Cells |
Q37728656 | The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice |
Q79450264 | The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties |
Q33322528 | The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections |
Q37572673 | The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants |
Q38124064 | The use of Toll-like receptor 7/8 agonists as vaccine adjuvants |
Q35824051 | Therapeutics targeting the innate immune system |
Q44329057 | Tick saliva suppresses IFN signalling in dendritic cells upon Borrelia afzelii infection |
Q42181181 | Tick salivary cystatin sialostatin L2 suppresses IFN responses in mouse dendritic cells |
Q35621860 | Tick sialostatins L and L2 differentially influence dendritic cell responses to Borrelia spirochetes |
Q37188449 | Toll-like receptor 4 mediates chronic restraint stress-induced immune suppression |
Q54539959 | Toll-like receptor-4 and mitogen-activated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome. |
Q37954396 | Toll-like receptors and diabetes: a therapeutic perspective |
Q28579752 | Total parenteral-nutrition-mediated dendritic-cell activation and infiltration into the small intestine in a rat model |
Q37237086 | Trovafloxacin enhances the inflammatory response to a Gram-negative or a Gram-positive bacterial stimulus, resulting in neutrophil-dependent liver injury in mice |
Q40046390 | Type I Interferon Induced by Streptococcus suis Serotype 2 is Strain-Dependent and May Be Beneficial for Host Survival |
Q37728235 | Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists |
Q35849930 | Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells |
Q36352579 | Up-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogens |
Q24814712 | Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis |
Search more.